Fig. 1.
Effect of acteoside treatment on weight loss in acute colitis. Mice with established acute dextran sulphate sodium (DSS)-induced colitis received either acteoside (600 µg a day, black diamonds) or phosphate-buffered saline (PBS) (no acteoside, white squares) per mouse over 5 days. The weight loss was determined over 8 days. The data presented are representative for three independent experiments with five mice per group each. Bars represent mean ± s.e.m. The curve progression of the acteoside-treated group is significantly different from the no-acteoside group (PGLM < 0·001). Statistics were calculated with spss, as described in Material and methods.